Resultados de la búsqueda 91-100 of 10143 for Raised CRP

  1. Hematología - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients with MIBG-avid, ALK wild type (or ALK unknown) disease will be randomized to one of three arms: A) current COG recommended high-risk therapy including ...

  3. Neurología - Ensayos clínicos - Mayo Clinic

    ... high (80-90%) frequency of MUC1 expression and variably high (unreported to 50%) HER2/neu (“HER2”) expression; (2) Cohort 2 focuses on primary or secondary ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... high (80-90%) frequency of MUC1 expression and variably high (unreported to 50%) HER2/neu (“HER2”) expression; (2) Cohort 2 focuses on primary or secondary ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Usual treatment after a complete response may include observation or high dose chemotherapy followed by an autologous stem cell transplant, however, it is not ...

  6. Cirugía - Ensayos clínicos - Mayo Clinic

    When the ascending aorta tears or ruptures, the risk dying is high even if surgery is done as soon as possible. Traditionally, when the ascending aorta gets ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    In addition, obesity, a chronic inflammatory state, is associated with increased colorectal cancer risk (5). However, the use of anti-inflammatory agents in ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients with MIBG-avid, ALK wild type (or ALK unknown) disease will be randomized to one of three arms: A) current COG recommended high-risk therapy including ...

  9. Neurología - Ensayos clínicos - Mayo Clinic

    ... high (80-90%) frequency of MUC1 expression and variably high (unreported to 50%) HER2/neu (“HER2”) expression; (2) Cohort 2 focuses on primary or secondary ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients with MIBG-avid, ALK wild type (or ALK unknown) disease will be randomized to one of three arms: A) current COG recommended high-risk therapy including ...